Melanoma
Conditions
Brief summary
The goal of this patient registry is to describe risk factors for bad prognosis of melanoma in Spain. The main questions it aims to answer are: * To describe socioeconomical individual risk factors associated with melanoma prognosis, such as gender, residence area or socioeconomic level. * To describe potentially modifiable characteristics of health care associated with prognosis, such as waiting times, type of centre that makes the diagnosis or use of teledermatology Participants data will be gathered for analysis, without any change in the way that they are being treated.
Interventions
None listed
Sponsors
Fundación Academia Española de Dermatología
Study design
Observational model
COHORT
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
ALL
Healthy volunteers
No
Inclusion criteria
* All consecutive patients with a diagnosis of invasive primary cutaneous melanoma in participating centres.
Exclusion criteria
* In-situ melanomas * non-cutaneous melanomas, * metastatic melanoma with unknown primary site.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| AJCC (American Joint Committee on Cancer) TNM stage (Tumor, node, metastasis) | 1 day At diagnosis | Staging based on tumor thickness and ulceration, spread to lymph nodes and spread to distant sites. |
| Breslow thickness | 1 day At diagnosis | Breslow thickness is the measurement of the depth of the melanoma from the surface of your skin down through to the deepest point of the tumour. |
Secondary
| Measure | Time frame |
|---|---|
| Time to progression | through study completion, an average of 3 years |
| Survival | through study completion, an average of 3 years |
Countries
Spain
Contacts
Primary ContactMercè Grau, MD
Backup ContactIgnacio Garcia-Doval, PhD
Outcome results
None listed